These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 25851312

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Continuous venovenous haemofiltration using a citrate buffered substitution fluid.
    Schmitz M, Taskaya G, Plum J, Hennersdorf M, Sucker C, Grabensee B, Hetzel GR.
    Anaesth Intensive Care; 2007 Aug; 35(4):529-35. PubMed ID: 18020071
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.
    Ong SC, Wille KM, Speer R, Tolwani AJ.
    Int J Artif Organs; 2014 Jun; 37(6):499-502. PubMed ID: 24811309
    [Abstract] [Full Text] [Related]

  • 6. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
    Raymakers-Janssen PAMA, Lilien M, van Kessel IA, Veldhoen ES, Wösten-van Asperen RM, van Gestel JPJ.
    Pediatr Nephrol; 2017 Oct; 32(10):1971-1978. PubMed ID: 28578542
    [Abstract] [Full Text] [Related]

  • 7. CRRT Regional Anticoagulation Using Citrate in the Liver Failure and Liver Transplant Population.
    Wonnacott R, Josephs B, Jamieson J.
    Crit Care Nurs Q; 2016 Oct; 39(3):241-51. PubMed ID: 27254640
    [Abstract] [Full Text] [Related]

  • 8. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP, Fernández Sarmiento J, Rojas Velasquez AM, González Chaparro LS, Gastelbondo Amaya R, Mulett Hoyos H, Tibaduiza D, Quintero Gómez AM.
    Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
    [Abstract] [Full Text] [Related]

  • 9. Impact of increasing post-filter ionized calcium target on filter lifespan in renal replacement therapy with regional citrate anticoagulation: A before-and-after study.
    Assefi M, Leurent A, Blanchard F, Quemeneur C, Deransy R, Monsel A, Constantin JM.
    J Crit Care; 2023 Dec; 78():154364. PubMed ID: 37379797
    [Abstract] [Full Text] [Related]

  • 10. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T.
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [Abstract] [Full Text] [Related]

  • 11. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD, Tung DD, Hallett D, Bailie T, Carvalhana V, Lee D, Ramganesh S, Richardson R, Mehta S, Lapinsky SE.
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [Abstract] [Full Text] [Related]

  • 12. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution.
    Shum HP, Chan KC, Yan WW.
    Ther Apher Dial; 2012 Feb; 16(1):81-6. PubMed ID: 22248200
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis.
    Zhang W, Bai M, Yu Y, Li L, Zhao L, Sun S, Chen X.
    Crit Care; 2019 Jan 24; 23(1):22. PubMed ID: 30678706
    [Abstract] [Full Text] [Related]

  • 14. Regional citrate anticoagulation in continuous hemodialysis--acid-base and electrolyte balance at an increased dose of dialysis.
    Morgera S, Haase M, Ruckert M, Krieg H, Kastrup M, Krausch D, Vargas-Hein O, Zuckermann-Becker H, Peters H, Pohlmeier R, Neumayer HH.
    Nephron Clin Pract; 2005 Jan 24; 101(4):c211-9. PubMed ID: 16155399
    [Abstract] [Full Text] [Related]

  • 15. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
    Rodriguez K, Srivaths PR, Tal L, Watson MN, Riley AA, Himes RW, Desai MS, Braun MC, Akcan Arikan A.
    PLoS One; 2017 Jan 24; 12(8):e0182134. PubMed ID: 28792509
    [Abstract] [Full Text] [Related]

  • 16. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R, Kram R, Morgera S, Slowinski T, Kindgen-Milles D.
    Ther Apher Dial; 2013 Apr 24; 17(2):202-12. PubMed ID: 23551677
    [Abstract] [Full Text] [Related]

  • 17. Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation.
    Wang PL, Meyer MM, Orloff SL, Anderson S.
    Am J Kidney Dis; 2004 Dec 24; 44(6):1110-4. PubMed ID: 15558534
    [Abstract] [Full Text] [Related]

  • 18. Regional citrate anticoagulation for continuous renal replacement therapy in severe burns-a retrospective analysis of a protocol-guided approach.
    Gille J, Sablotzki A, Malcharek M, Raff T, Mogk M, Parentin T.
    Burns; 2014 Dec 24; 40(8):1593-601. PubMed ID: 24612996
    [Abstract] [Full Text] [Related]

  • 19. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).
    Mitchell A, Daul AE, Beiderlinden M, Schäfers RF, Heemann U, Kribben A, Peters J, Philipp T, Wenzel RR.
    Clin Nephrol; 2003 Feb 24; 59(2):106-14. PubMed ID: 12608553
    [Abstract] [Full Text] [Related]

  • 20. Advances in continuous renal replacement therapy: citrate anticoagulation update.
    Tolwani A, Wille KM.
    Blood Purif; 2012 Feb 24; 34(2):88-93. PubMed ID: 23095407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.